Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
1671 Preoperative gemcitabine based chemo-radiotherapy in locally advanced non metastatic pancreatic adenocarcinoma Department of Surgical Oncology Prof. Doaa Wadie Maximous Dawoud 2009
1672 Initial Results of Bladder Preserving Approach by Chemo-Radiotherapy in Patients with Muscle Invading Transitional Cell Carcinoma
 		Department of Surgical Oncology Ahmed Mokhtar Abdel- Rahim Abdel-Moneem 2009
1673 The role of platelets CD40 ligand (CD154) in acute coronary syndromes Department of Clinical Pathology Prof. Douaa Mohamed Sayed Hussein 2009
1674 A novel method for automated tumour delineation on PET/CT for radiotherapy treatment planning. Department of Radiotherapy and Nuclear medicine Dr. Moamen Mohamed Omran Moustafa Aly 2009
1675 Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study. Department of Clinical Pathology Prof. Eman Massad Zaki El-Hefny 2008
1676 Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study. Department of Clinical Pathology Prof. Hosny Badrawy Hamed Omran 2008
1677 Diagnostic performance and predictive value of rheumatoid factor anti-cyclic-citrullinated peptide antibodies and HLA-DRB1 locus genes in rheumatoid arthritis Department of Clinical Pathology Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2008
1678 Pharmacokinetics of oral tramadol in patients with liver cancer.
 		Department of Anesthesia, Intensive care and Pain management Prof. Mustafa Galal Mustafa Hassan 2008
1679 Diagnostic performance and predictive value of rheumatoid factor anti-cyclic-citrullinated peptide antibodies and HLA-DRB1 locus genes in rheumatoid arthritis Department of Clinical Pathology Prof. Eman Massad Zaki El-Hefny 2008
1680 Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study Department of Clinical Pathology Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2008